S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

NWBO Northwest Biotherapeutics Inc (QB)

0.2998

-0.0002 (-0.07%)

07 Sep 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more Northwest Biotherapeutics (QB) Charts.

Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more Northwest Biotherapeutics (QB) Charts.

Northwest Biotherapeutics Inc (QB) News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 4 September 2024 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 14 August 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 10 August 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 9 August 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 3 August 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 31 July 2024 (1 month ago) • Edgar (US Regulatory)

Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher
Tuesday 18 June 2024 (3 months ago) • AllPennyStocks.com

Form 8-K - Current report
Wednesday 5 June 2024 (3 months ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Tuesday 4 June 2024 (3 months ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Thursday 23 May 2024 (4 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 11 May 2024 (4 months ago) • Edgar (US Regulatory)

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Saturday 2 March 2024 (6 months ago) • Edgar (US Regulatory)

More Northwest Biotherapeutics Inc (QB) News Articles

AUD vs US Dollar

Invesco QQQ Trust Series 1

Verizon Communications

S&P ASX 300 Metals and M...

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions